Lipid Metabolism and Cancer Cell Regulation

Lipid metabolism encompasses the complex network of biosynthetic and degradative pathways that generate and modify fatty acids, phospholipids and sterols. In cancer cells, this network is frequently reprogrammed to support rapid proliferation, membrane biogenesis and resistance to stress. Key enzymes in de novo lipogenesis and fatty acid desaturation become upregulated, supplying mono-unsaturated fatty acids for new membranes and signalling lipids that modulate oncogenic pathways. At the same time, altered lipid uptake and storage enable tumours to adapt to fluctuating nutrient availability and hypoxic conditions.

Emerging evidence indicates that dysregulated lipid metabolism contributes directly to cancer cell survival and therapy resistance. Enhanced activity of desaturases, elongases and transporters not only fulfils bioenergetic and structural needs but also regulates redox balance and cell-death programmes such as ferroptosis. Interplay between lipid species and transcriptional regulators—including sterol regulatory element-binding proteins and peroxisome proliferator-activated receptors—further integrates metabolic cues with proliferation and differentiation signals. Understanding these interconnections offers opportunities to target metabolic vulnerabilities selectively in cancer cells while sparing normal tissues.

Research from Nature Portfolio

In colorectal cancer models, inhibition of stearoyl-CoA desaturase 1 (SCD1) has been shown to shift lipid homeostasis towards ceramide accumulation, triggering mitochondrial dysfunction, reactive oxygen species production and cytochrome C-mediated apoptosis. These findings reveal that modulation of endogenous ceramide synthesis is a critical mechanism by which SCD1 controls tumour cell fate. In vivo, pharmacological blockade of SCD1 delayed xenograft growth, an effect reversed by ceramide biosynthesis inhibitors, underscoring the therapeutic potential of targeting this lipid–ceramide axis.

Lipid Metabolism and Cancer Cell Regulation publication trend

The graph below shows the total number of articles in lipid metabolism and cancer cell regulation across all publications each year (not limited to Nature Index journals).

Technical terms

Stearoyl-CoA desaturase 1 (SCD1): Enzyme that converts saturated fatty acids into monounsaturated fatty acids, central to lipid desaturation in cancer.

Ceramide: A sphingolipid intermediate that serves as a pro-apoptotic messenger when accumulated within cells.

Ferroptosis: Iron-dependent form of regulated cell death driven by lipid peroxidation.

Unfolded protein response (UPR): Cellular stress pathway activated by accumulation of misfolded proteins in the endoplasmic reticulum, which can lead to apoptosis if persistent.

Lipotoxicity: Cellular damage resulting from excessive accumulation of lipid species such as free fatty acids or ceramides.

Structural lipidomics: Analytical approach employing mass spectrometry to resolve fine structural details of lipid molecules, including double-bond positions and isomerism.

References

1. Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis. Scientific Reports (2016).
2. A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response. Experimental & Molecular Medicine (2024).
3. Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation. Leukemia (2024).
4. Metabolic Pathway of Monounsaturated Lipids Revealed by In-Depth Structural Lipidomics by Mass Spectrometry. Research (2023).